Human Papilloma Virus - HPV
How dangerous is HPV? The medical facts may surprise you!
www.health-science-report.comAdvertise here

Best Fundraiser Ever!
No up front costs. No minimums.
75% profit. No delays. Start today.
For groups, teams, individuals, schools.

www.NorthPoleFundraising.com

Human Papilloma Virus Research - Prevention


Diagn Cytopathol. 2005 May;32(5):310-4.

Noncorrelating Pap tests and cervical biopsies: histological predictors of subsequent correlation.

Joste NE, Wolz M, Pai RK, Lathrop SL. Department of Pathology, University of New Mexico School of Medicine, Albuquerque, 87131, USA.

Lack of correlation between dysplastic cervicovaginal Papanicolaou (Pap) tests and subsequent cervical biopsies raises the concern that a significant squamous intraepithelial lesion (SIL) may go unconfirmed. Additional tissue sections of cervical biopsies may detect SILs after noncorrelation on initial sections. Complete step sectioning of paraffin blocks was undertaken on 111 noncorrelating biopsy specimens from 95 patients and selected slides were reviewed for the presence of SIL. The initial negative biopsy slides were evaluated for four histological features: chronic cervicitis, acute cervicitis, mucosal erosion, and squamous atypia. Twenty-seven biopsies (24.3%) demonstrated the presence of a SIL in deeper levels. The presence of squamous atypia was significantly associated with the presence of dysplasia deeper in the block (P < 0.002). Acute and chronic cervicitis was seen roughly equally. Additional tissue levels are a productive way of confirming SILs, and squamous atypia allows a refined selection of negative cervical biopsies most likely to reveal an SIL on review of deeper levels. Copyright 2005 Wiley-Liss, Inc.


Sex Transm Dis. 2005 May;32(5):293-9.

Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease.

Haggerty CL, Peipert JF, Weitzen S, Hendrix SL, Holley RL, Nelson DB, Randall H, Soper DE, Wiesenfeld HC, Ness RB; PID Evaluation and Clinical Health (PEACH) Study Investigators. University of Pittsburgh, Department of Epidemiology, Pittsburgh, Pennsylvania 15261, USA.

OBJECTIVE: The objective of this study was to assess the risk profile for chronic pelvic pain (CPP) after pelvic inflammatory disease (PID). STUDY: Multivariate logistic regression was used to assess risk factors for CPP in a longitudinal study of 780 predominately black, urban women with clinically suspected PID: complaints of acute pain (<30 days); a clinical finding of pelvic tenderness; and leukorrhea, mucopurulent cervicitis, or untreated gonococcal or chlamydial cervicitis. CPP was defined as pain reported at >or=2 consecutive interviews conducted every 3 to 4 months for 2 to 5 years. RESULTS: Nonblack race (odds ratio [OR], 2.17; 95% confidence interval [CI], 1.31-3.58), being married (OR, 2.06; 95% CI, 1.02-4.18), a low SF-36 mental health composite score (OR, 2.71; 95% CI, 1.69-4.34), >or=2 prior PID episodes (OR, 2.84; 95% CI, 1.07-7.54), and smoking (OR, 1.65; 95% CI, 1.01-2.71) independently predicted CPP. Histologic endometritis or evidence of endometrial Neisseria gonorrhoeae or Chlamydia trachomatis infection was negatively associated with CPP (OR, 0.69; 95% CI, 0.44-1.10). CONCLUSIONS: A range of demographic, clinical, historical, and behavioral factors predict CPP after PID.


Sex Transm Infect. 2005 Feb;81(1):73-8.

Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection.

Falk L, Fredlund H, Jensen JS. Department of Dermatology and Venereology, University Hospital, Orebro, SE -701 85 Orebro, Sweden.

OBJECTIVES: To study the prevalence, symptoms, and signs of Mycoplasma genitalium and Chlamydia trachomatis infections in women attending a Swedish STD clinic, accessible for both sexes, and in a group of young women called in the cervical cancer screening programme. METHODS: A cross sectional study among female STD clinic attendees in Orebro and a study among women called for Papanicolaou smear screening. Attendees were examined for urethritis and cervicitis. First void urine and endocervical samples were tested for M genitalium and C trachomatis. RESULTS: The prevalence of C trachomatis and M genitalium in the STD clinic population was 10% (45/465) and 6% (26/461), respectively. Dual infection was diagnosed in four women. In the cancer screening group of women the corresponding prevalence was 2% (1/59) and 0%, respectively. Among the STD clinic attendees there were no significant differences in symptoms (32% v 23%, RR 1.4, 95% CI 0.6 to 3.4) or signs (71% v 50%, RR 1.4, 95% CI 0.9 to 2.3) between C trachomatis and M genitalium infections. Microscopic signs of cervicitis were significantly more common among M genitalium and C trachomatis infected women than in the cancer screening group of women. 56% (15/27) of male partners of M genitalium infected women were infected with M genitalium compared to 59% of male partners of C trachomatis infected women who were infected with C trachomatis (p = 0.80). CONCLUSIONS: M genitalium is a common infection associated with cervicitis and with a high prevalence of infected sexual partners supporting its role as a cause of sexually transmitted infection.


Obstet Gynecol Clin North Am. 2003 Dec;30(4):795-808.

Sexually transmitted infections and contraceptives: selective issues.

Stuart GS, Castano PM. Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9032, USA.

It is important to examine the successful completed research and use it to move forward in practice to halt the almost 50% unintended pregnancy rate in the United States and the continued worldwide epidemic of HIV and other STIs. A significant development has been the evidence supporting the IUD as a valuable contraceptive option available to many women, including women who are HIV infected, with no increased risks of infertility or PID. Evidence exists that OCPs may increase chlamydial infection acquisition and cervicitis, but it is unlikely that OCP use is associated with PID. The lack of female-controlled dual method protection remains a void, but with the introduction of products such as FemCap and Reality condom and the continuing progress of microbicides and spermicides, the future is brighter. Clearly research into the interactions of STIs and contraceptives must continue to discern how best to approach a resolution to these public health concerns that affect women and the global population.

    Publication Types:
  • Review
  • Review, Tutorial

Human Papilloma Virus Research - Cervicitis Prediction and Prevention Links

Cervicitis Info - A medical encyclopedia article on the topic - Cervicitis Prevention.

Promoting Prevention - Useful information concerning safety precautions against various STDs.

Women's Conditions - Here you can ask medical questions and read frequently asked questions and answers for them.

Picture of HPV Virus, HPV in a Woman, HPV Man, HPV in Man, HPV Virus SymptomHPV Genital Wart, HPV Transmission, Does HPV Go Away, How is HPV Transmitted, Gardasil HPV New VaccineHuman Papillomavirus HPV, Human Papilloma Virus Treatment, Human Papillomavirus Vaccine, Genital Wart, Genital WartsCervical Dysplasia and HPV, Cervical Dysplasia Natural Treatment, Recurrence of Cervical Dysplasia, ASCUS Pap Smear, Abnormal Pap Smear Result

Additional site navigation: Cervical Cancer Human Papilloma Virus, Human Papillomavirus Picture, Human Papilloma Virus Symptom, Human Papillomavirus HPV, Human Papillomavirus Vaccine, Human Papillomavirus, Human Papillomavirus Infection, Human Papilloma Virus Cure, HPV Human Papilloma Virus, Human Papilloma Virus Treatment
Popular topics: Human Papilloma Virus Vaccine, Human Papilloma Virus and Pregnancy, Human Papilloma Virus Cure, Human Papilloma Virus Treatment, Human Papilloma Virus Symptom, Type of Human Papilloma Virus, Human Papillomavirus HPV, Cervical Cancer and Human Papilloma Virus, Human Papillomavirus Picture, Human Papilloma Virus

Treatment
Dangers
Prevention

Copyright © 2002-2009 www.hpv-human-papilloma-virus-research.org
All Rights Reserved.

There are over 100 hpv types; an organism can cope with them only if the immune system is strong enough; a natural remedy can help in boosting the imune system and preventing getting a vaginal wart or other HPV-related disorders.